Page last updated: 2024-11-03

ritanserin and Anesthesia

ritanserin has been researched along with Anesthesia in 6 studies

Ritanserin: A selective and potent serotonin-2 antagonist that is effective in the treatment of a variety of syndromes related to anxiety and depression. The drug also improves the subjective quality of sleep and decreases portal pressure.
ritanserin : A thiazolopyrimidine that is 5H-[1,3]thiazolo[3,2-a]pyrimidin-5-one which is substituted at position 7 by a methyl group and at position 6 by a 2-{4-[bis(4-fluorophenyl)methylidene]piperidin-1-yl}ethyl group. A potent and long-acting seratonin (5-hydroxytryptamine, 5-HT) antagonist of the subtype 5-HT2 (Ki = 0.39 nM), it is used in the treatment of a variety of disorders including anxiety, depression and schizophrenia. It has little sedative action.

Anesthesia: A state characterized by loss of feeling or sensation. This depression of nerve function is usually the result of pharmacologic action and is induced to allow performance of surgery or other painful procedures.

Research Excerpts

ExcerptRelevanceReference
"In ritanserin-treated rats, section of the carotid sinus nerves and vagus nerves or ICS 205."1.28The cardiovascular effects of quipazine are mediated by peripheral 5-HT2 and 5-HT3 receptors in anaesthetized rats. ( Bouysset, F; Laubie, M; Schmitt, H; Vayssettes-Courchay, C; Verbeuren, TJ, 1990)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19901 (16.67)18.7374
1990's4 (66.67)18.2507
2000's1 (16.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fink, G1
Dow, RC1
McQueen, JK1
Bennie, JG1
Carroll, SM1
Siddiqui, A1
Kotecha, K1
Salicioni, AM1
Kalia, V1
Murray, JF1
Wilson, CA1
Bernardi, M1
Di Sarra, B1
Montecchiani, G1
Re, L1
Rossini, L1
Tonnini, C1
Vayssettes-Courchay, C1
Bouysset, F1
Verbeuren, TJ1
Laubie, M1
Schmitt, H1
Dreteler, GH1
Wouters, W1
Saxena, PR1
Ramage, AG1

Other Studies

6 other studies available for ritanserin and Anesthesia

ArticleYear
Serotonergic 5-HT2A receptors important for the oestradiol-induced surge of luteinising hormone-releasing hormone in the rat.
    Journal of neuroendocrinology, 1999, Volume: 11, Issue:1

    Topics: Anesthesia; Anesthetics; Animals; Cyclic S-Oxides; Diestrus; Estradiol; Female; Fluoxetine; Gonadotr

1999
Serotonin inhibits luteinizing hormone release via 5-HT1A receptors in the zona incerta of ovariectomised, anaesthetised rats primed with steroids.
    Neuroendocrinology, 2000, Volume: 72, Issue:5

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Anesthesia; Animals; Estradiol; Female; Luteinizing Hormone;

2000
[Persistence of the control of the fluctuations of heart rate in the anesthetized and pithed adult rat. Effect of enteraminergic drugs].
    Bollettino della Societa italiana di biologia sperimentale, 1991, Volume: 67, Issue:1

    Topics: Anesthesia; Animals; Decerebrate State; Depression, Chemical; Dose-Response Relationship, Drug; Ethe

1991
The cardiovascular effects of quipazine are mediated by peripheral 5-HT2 and 5-HT3 receptors in anaesthetized rats.
    European journal of pharmacology, 1990, Aug-02, Volume: 184, Issue:1

    Topics: Amidines; Anesthesia; Animals; Blood Pressure; Carotid Body; Denervation; Heart Rate; Hemodynamics;

1990
Comparison of the cardiovascular effects of the 5-HT1A receptor agonist flesinoxan with that of 8-OH-DPAT in the rat.
    European journal of pharmacology, 1990, May-16, Volume: 180, Issue:2-3

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Anesthesia; Animals; Antihypertensive Agents; Atropine; Bloo

1990
Examination of the effects of some 5-HT2 receptor antagonists on central sympathetic outflow and blood pressure in anaesthetised cats.
    Naunyn-Schmiedeberg's archives of pharmacology, 1988, Volume: 338, Issue:6

    Topics: Anesthesia; Animals; Blood Pressure; Cats; Cinanserin; Cyproheptadine; Male; Metergoline; Methiothep

1988